FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1897802257> ?p ?o ?g. }

• W1897802257 endingPage "274" @default.
• W1897802257 startingPage "264" @default.
• W1897802257 abstract "Hepatocellular carcinoma (HCC) is an intrinsically chemotherapy refractory malignancy. Development of effective therapeutic regimens would be facilitated by improved preclinical HCC models. Currently, most models consist of subcutaneous human tumor transplants in immunodeficient mice; however, these do not reproduce the extensive liver disease associated with HCC or metastasize. To address this deficiency, we developed an orthotopic model. Human HCC cells were transfected with the gene encoding secretable beta-subunit human choriogonadotropin (beta-hCG), which was used as a surrogate marker of tumor burden. The HCC cells were implanted into the left liver lobe of severe combined immunodeficient (SCID) mice, after which the efficacy of different therapies was evaluated on established, but liver-confined human Hep3B cell line HCC. Treatments included sorafenib or metronomic chemotherapy using cyclophosphamide (CTX), UFT, an oral 5-fluorouracil prodrug, or doxorubicin either alone or in various combinations, with or without an antiangiogenic agent, DC101, an anti-vascular endothelial growth factor receptor-2 antibody. Sorafenib inhibited tumor growth in a dose-dependent manner but caused severe weight loss in SCID mice, thus necessitating use of DC101 in subsequent experiments. Although less toxicity was observed using either single or doublet metronomic chemotherapy without any added antiangiogenic agent, none, provided survival benefit. In contrast, significantly improved overall survival was observed using various combinations of metronomic chemotherapy regimens such as UFT + CTX with DC101. In conclusion, using this model of liver-confined but advanced HCC suggests that the efficacy of a targeted antiangiogenic drug or metronomic chemotherapy can be mutually enhanced by concurrent combination treatment." @default.
• W1897802257 created "2016-06-24" @default.
• W1897802257 creator A5008058822 @default.
• W1897802257 creator A5010799165 @default.
• W1897802257 creator A5013579372 @default.
• W1897802257 creator A5035593944 @default.
• W1897802257 creator A5061940667 @default.
• W1897802257 date "2010-03-01" @default.
• W1897802257 modified "2023-10-17" @default.
• W1897802257 title "Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma" @default.
• W1897802257 cites W129214241 @default.
• W1897802257 cites W1482290746 @default.
• W1897802257 cites W1483646805 @default.
• W1897802257 cites W1579189600 @default.
• W1897802257 cites W1929987490 @default.
• W1897802257 cites W1943173994 @default.
• W1897802257 cites W1966448677 @default.
• W1897802257 cites W1967600348 @default.
• W1897802257 cites W1968298928 @default.
• W1897802257 cites W1970992278 @default.
• W1897802257 cites W1971837077 @default.
• W1897802257 cites W1978331797 @default.
• W1897802257 cites W1979372400 @default.
• W1897802257 cites W1984750597 @default.
• W1897802257 cites W1986078611 @default.
• W1897802257 cites W1990095055 @default.
• W1897802257 cites W1990275745 @default.
• W1897802257 cites W1992184276 @default.
• W1897802257 cites W1994193851 @default.
• W1897802257 cites W1998148830 @default.
• W1897802257 cites W1999060978 @default.
• W1897802257 cites W2026866220 @default.
• W1897802257 cites W2029883816 @default.
• W1897802257 cites W2032231188 @default.
• W1897802257 cites W2034548257 @default.
• W1897802257 cites W2042165138 @default.
• W1897802257 cites W2056003066 @default.
• W1897802257 cites W2058778835 @default.
• W1897802257 cites W2070396671 @default.
• W1897802257 cites W2074470232 @default.
• W1897802257 cites W2075549113 @default.
• W1897802257 cites W2079238642 @default.
• W1897802257 cites W2079856293 @default.
• W1897802257 cites W2084957288 @default.
• W1897802257 cites W2087146189 @default.
• W1897802257 cites W2098321535 @default.
• W1897802257 cites W2100512801 @default.
• W1897802257 cites W2101330142 @default.
• W1897802257 cites W2103323117 @default.
• W1897802257 cites W2111489144 @default.
• W1897802257 cites W2120191503 @default.
• W1897802257 cites W2127580939 @default.
• W1897802257 cites W2130596312 @default.
• W1897802257 cites W2137268781 @default.
• W1897802257 cites W2147094816 @default.
• W1897802257 cites W2152251876 @default.
• W1897802257 cites W2164190676 @default.
• W1897802257 cites W2167661193 @default.
• W1897802257 cites W2168167705 @default.
• W1897802257 cites W2169965478 @default.
• W1897802257 cites W2170722580 @default.
• W1897802257 cites W2409076127 @default.
• W1897802257 cites W2419317670 @default.
• W1897802257 cites W56771330 @default.
• W1897802257 doi "https://doi.org/10.1593/neo.91872" @default.
• W1897802257 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2838774" @default.
• W1897802257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20234820" @default.
• W1897802257 hasPublicationYear "2010" @default.
• W1897802257 type Work @default.
• W1897802257 sameAs 1897802257 @default.
• W1897802257 citedByCount "47" @default.
• W1897802257 countsByYear W18978022572012 @default.
• W1897802257 countsByYear W18978022572013 @default.
• W1897802257 countsByYear W18978022572014 @default.
• W1897802257 countsByYear W18978022572015 @default.
• W1897802257 countsByYear W18978022572016 @default.
• W1897802257 countsByYear W18978022572017 @default.
• W1897802257 countsByYear W18978022572018 @default.
• W1897802257 countsByYear W18978022572020 @default.
• W1897802257 countsByYear W18978022572022 @default.
• W1897802257 crossrefType "journal-article" @default.
• W1897802257 hasAuthorship W1897802257A5008058822 @default.
• W1897802257 hasAuthorship W1897802257A5010799165 @default.
• W1897802257 hasAuthorship W1897802257A5013579372 @default.
• W1897802257 hasAuthorship W1897802257A5035593944 @default.
• W1897802257 hasAuthorship W1897802257A5061940667 @default.
• W1897802257 hasBestOaLocation W18978022571 @default.
• W1897802257 hasConcept C108215921 @default.
• W1897802257 hasConcept C126322002 @default.
• W1897802257 hasConcept C143998085 @default.
• W1897802257 hasConcept C2776694085 @default.
• W1897802257 hasConcept C2776755627 @default.
• W1897802257 hasConcept C2777292972 @default.
• W1897802257 hasConcept C2777802072 @default.
• W1897802257 hasConcept C2778019345 @default.
• W1897802257 hasConcept C2778695046 @default.
• W1897802257 hasConcept C2781303535 @default.
• W1897802257 hasConcept C502942594 @default.

• next